Peptide record

TPDB10964

Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity standard
27 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB10964
Antibacterial Anticancer Antifungal Antiparasitic Antiviral Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP Peptipedia Antifungipept CAFPdb ToxinPred 3.0
standard
No
A 27-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, Peptipedia, and other sources, with an available 3D structural model.
Sequence
GIGGVLLSAGKAALKGLTKVLAEKYAN
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C120H208N32O34
RDCQHMFPW
AGL
2643.17
10.31
4
1
14
+3
-0.36
0.500
126.67
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
0.56
4
Residue Composition
number
5
A
0
R
1
N
0
D
0
C
1
E
0
Q
5
G
0
H
1
I
5
L
4
K
0
M
0
F
0
P
1
S
1
T
0
W
1
Y
2
V
Amino Acid Distribution
A: 5 R: 0 N: 1 D: 0 C: 0 E: 1 Q: 0 G: 5 H: 0 I: 1 L: 5 K: 4 M: 0 F: 0 P: 0 S: 1 T: 1 W: 0 Y: 1 V: 2
Chemical Descriptors
27 reviewed residue count
C120H208N32O34 sequence-only estimate (linear, free termini)
2643.17 sequence-only estimate (linear, free termini)
10.31 sequence-only estimate (linear, free termini)
+3 sequence-only estimate (linear, free termini)
-0.36 sequence-only estimate (linear, free termini)
0.500 sequence-only estimate (linear, free termini)
Evidence Records 16 records
Evidence 1 Activity

Activity

MIC
Antibacterial
18.8 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class.
Proteomics: Only active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 2 Activity

Activity

MIC
Antibacterial
>100 µg/mL

Target

E.coli ATCC 25922

Source & Reference

dbAMP

Other

y active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 3 Activity

Activity

MIC
Antibacterial
>100 µg/mL

Target

B.subtilis ATCC 6633

Source & Reference

dbAMP

Other

00 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 4 Activity

Activity

MIC
Antifungal
18.8 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

dbAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class.
Proteomics: Only active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 5 Activity

Activity

MIC
Antifungal
>100 µg/mL

Target

E.coli ATCC 25922

Source & Reference

dbAMP CAFPdb Antifungipept

Other

y active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 6 Activity

Activity

MIC
Antifungal
>100 µg/mL

Target

B.subtilis ATCC 6633

Source & Reference

dbAMP CAFPdb Antifungipept

Other

00 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 7 Activity

Activity

MIC
Antiparasitic
18.8 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

NA

Other

Proteomics: Only active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 8 Activity

Activity

MIC
Antiparasitic
>100 µg/mL

Target

E.coli ATCC 25922

Source & Reference

NA

Other

y active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 9 Activity

Activity

MIC
Antiparasitic
>100 µg/mL

Target

B.subtilis ATCC 6633

Source & Reference

NA

Other

00 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 10 Activity

Activity

MIC
Antiviral
18.8 µg/mL

Target

Staphylococcus aureus ATCC 25923

Source & Reference

NA

Other

Proteomics: Only active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 11 Activity

Activity

MIC
Antiviral
>100 µg/mL

Target

E.coli ATCC 25922

Source & Reference

NA

Other

y active peptides (i.e. AMPs) with MIC 100 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 12 Activity

Activity

MIC
Antiviral
>100 µg/mL

Target

B.subtilis ATCC 6633

Source & Reference

NA

Other

00 ug/ml), S. aureus ATCC 25923 (MIC 18.8 ug/ml), E.coli ATCC 25922 (MIC >100 ug/ml), and B.subtilis ATCC 6633 (MIC >100 ug/ml).
Evidence 13 Activity

Activity

9% Hemolysis
Toxicity
125 µg/mL
Hemolytic Cytotoxic
9% Hemolysis | 125 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
There are abundant antimicrobial peptides in brains of two kinds of Bombina toads. | J Proteome Res | 2011
Evidence 14 Activity

Activity

3% Hemolysis
Toxicity
62.5 µg/mL
Hemolytic Cytotoxic
3% Hemolysis | 62.5 | µg/mL | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
There are abundant antimicrobial peptides in brains of two kinds of Bombina toads. | J Proteome Res | 2011
Evidence 15 Activity

Activity

1% Hemolysis
Toxicity
125 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 125 | µg/mL | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
There are abundant antimicrobial peptides in brains of two kinds of Bombina toads. | J Proteome Res | 2011
Evidence 16 Activity

Activity

1% Hemolysis
Toxicity
62.5 µg/mL
Hemolytic Cytotoxic
1% Hemolysis | 62.5 | µg/mL | target cell: Rabbit erythrocytes

Target

Rabbit erythrocytes

Source & Reference

NA
DBAASP
There are abundant antimicrobial peptides in brains of two kinds of Bombina toads. | J Proteome Res | 2011